共 47 条
HOW SHOULD P-2X PURINOCEPTORS BE CLASSIFIED PHARMACOLOGICALLY
被引:161
作者:
KENNEDY, C
[1
]
LEFF, P
[1
]
机构:
[1] FISONS PLC,RES & DEV LABS,DEPT PHARMACOL,LOUGHBOROUGH LE11 0RH,LEICS,ENGLAND
基金:
美国国家卫生研究院;
英国医学研究理事会;
关键词:
D O I:
10.1016/S0165-6147(00)89010-0
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
When ATP is released as a neurotransmitter from central and peripheral nerves it acts at P-2X purinoceptors to produce postsynaptic depolarization and excitation. The P-2X purinoceptor was originally classified on the basis of the relative agonist potencies of ATP and a number of its structural analogues. However, it is now clear that the potency of some agonists is greatly decreased by breakdown by ectonucleotidase enzymes, leading to an incorrect determination of agonist potency order. In this article, Charles Kennedy and Paul Leff discuss recent results that indicate that the established classification of P-2X purinoceptors is no longer valid and needs redefinition.
引用
收藏
页码:168 / 174
页数:7
相关论文